Twist Bioscience Corporation (TWST) Publishes Preclinical Da

Twist Bioscience Corporation (TWST) Publishes Preclinical Data in Diabetes Validating GLP-1R Antagonist Antibody as Potential Treatment for Congenital Hyperinsulinism

Twist Bioscience Corporation (TWST) Publishes Preclinical Data in Diabetes Validating GLP-1R Antagonist Antibody as Potential Treatment for Congenital Hyperinsulinism

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Philadelphia , Pennsylvania , United States , Emilym Leproust , , Division Of Endocrinology , Twist Bioscience Corporation , Congenital Hyperinsulinism Center , Twist Antibody Optimization ,